UBS reiterates Nvidia stock buy rating amid $1.5 trillion AI investment view

UBS reiterated its buy rating and $175 price target for Nvidia, citing the company's expanding AI infrastructure customer base and visibility into significant future investments, estimating Nvidia could generate $40-50 billion in revenue per gigawatt of AI data center capacity, potentially implying datacenter revenue of around $400 billion annually. Furthermore, Micron Technology was selected as the first supplier for Nvidia's next-generation memory solution, SOCAMM, giving Micron an early advantage in the AI server memory market. Nvidia also announced a collaboration with Novo Nordisk to accelerate AI-powered drug discovery.

Analysis

UBS has reaffirmed its buy rating and a $175.00 price target for Nvidia, underpinned by an expanding customer base and clear visibility into approximately $1.5 trillion of AI infrastructure investments anticipated over the next few years. This outlook is further supported by Nvidia's remarkable 86% year-over-year revenue growth and a robust 70% gross profit margin, contributing to an "EXCELLENT" financial health score according to InvestingPro. The company's demand is notably broadening from U.S. hyperscalers to sovereign states and traditional industries, with its supply chain, software, and product roadmap scaling in tandem. UBS highlights Nvidia's potential to generate $40-50 billion in revenue per gigawatt of AI data center capacity, implying a potential annual datacenter revenue of around $400 billion, significantly above current UBS estimates for 2026 and addressing concerns about near-term earnings peaks. Strategic developments further enhance this outlook, including Micron Technology's selection as the primary supplier for Nvidia’s SOCAMM next-generation memory, granting Micron an early lead in the AI server memory market, and collaborations with Novo Nordisk to leverage AI for drug discovery and Beamr Imaging for advanced video compression in autonomous vehicles. These initiatives, coupled with the stock trading near its 52-week high of $153.13, underscore Nvidia's dominant position and ongoing expansion in the AI sector.

Key Decisions for Investors

• Given the reaffirmed buy rating, substantial AI-driven growth prospects, and strong financial performance, consider maintaining or initiating exposure to NVDA, while closely monitoring its valuation as it trades near its 52-week high.
• Evaluate the strategic importance and execution of new partnerships, such as with Micron for advanced memory solutions and Novo Nordisk for AI in drug discovery, as these could unlock new revenue streams and solidify market leadership.
• Track progress towards the projected $1.5 trillion AI infrastructure spend and Nvidia's ability to convert this into its targeted $400 billion annual datacenter revenue, as these are crucial for sustaining long-term growth expectations.